Skip to content

Move in Mind: Program for Reducing Musculoskeletal Pain

Move in Mind: Program for Reducing Musculoskeletal Pain

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04381975
Enrollment
0
Registered
2020-05-11
Start date
2024-01-01
Completion date
2024-12-31
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Musculoskeletal Pain

Brief summary

The present pilot study will explore the range of mental and physical health benefits associated with a Rolfing®-based intervention program (Move in Mind). To assess the effects of this program on pain management and various psychological outcomes, the investigator's study will be offered to individuals with mild chronic musculoskeletal pain (e.g., lower back pain, neck pain, shoulder pain, knee pain, arthritic pain). Shortened from ten to six sessions and adapted to a group setting by Rolfing® instructor Monica Canducci, the intervention will be delivered weekly by Ms. Canducci, who is certified in Rolfing®. The program will target the potential associations of the Move in Mind program with better pain management (primary outcome) as well as increased body awareness and presence, increased well-being, and better stress management (secondary outcomes). Interested participants will be asked to complete a battery of questionnaires and psychometric scales to assess the variables of interest before (baseline) and after their participation in the Move in Mind program (six-week follow-up). A waitlist control group will also be assessed at baseline and follow-up and will then receive the Move in Mind sessions subsequently and also assessed after their participation.

Interventions

BEHAVIORALMove in Mind Program

Each of the six Move in Mind sessions will take place once a week for approximately 1.5 hours, with 12-17 individuals participating per class. The material and exercises taught will include physical floor exercises, breathing exercises, as well as awareness training.

BEHAVIORAL6 Week Waitlist Control

The waitlist control group will receive the Move in Mind program after 6 weeks.

Sponsors

McGill University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 or older * experiencing a type of mild musculoskeletal pain (e.g., pain related to the muscles, ligaments, bones, joints, or nerve compression)

Exclusion criteria

* pregnant * receiving treatment for severe chronic pain * have had recent concussions or fractures as a result of accidents

Design outcomes

Primary

MeasureTime frameDescription
Difference in quality and intensity of pain at the end of treatment/waitlist period.7 days after last intervention session in week sixThe short-form McGill Pain Questionaire (SF-MPQ) is a 15-item self-report measure that assesses the quality and intensity of a patient's pain. Descriptors either represent the sensory dimension (items 1-11; e.g., Stabbing) or the affective dimension of pain experience (items 12-15; e.g., Punishing-Cruel). Patients respond to the SF-MPQ using an intensity scale ranging from 0 (none) to 3 (severe).

Secondary

MeasureTime frameDescription
Difference in changes in physical and mental health at the end of treatment/waitlist period.7 days after last intervention session in week six12-item Short Form Health Survey (SF-12 version)
Difference in perceived stress at the end of treatment/waitlist period.7 days after last intervention session in week sixThe Perceived Stress Scale is a 10-item scale measuring the degree to which situations in the past month are perceived as overwhelming or unpredictable.
Difference in positive and negative affect at the end of treatment/waitlist period.7 days after last intervention session in week sixThe Positive and Negative Affect Schedule (PANAS)
Difference in depressive disorder diagnoses and depressive symptom severity at the end of treatment/waitlist period.7 days after last intervention session in week sixPatient Health Questionnaire (PHQ-9)
Difference in satisfaction with Move in Mind program at the end of treatment/waitlist period.7 days after last intervention session in week six8 items based on Frayn et al. (2020). Items such as The program was easy to follow or I can see myself using what I learned in the program in the long term are rated on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026